FR2430939A1 - Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant - Google Patents

Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant

Info

Publication number
FR2430939A1
FR2430939A1 FR7917796A FR7917796A FR2430939A1 FR 2430939 A1 FR2430939 A1 FR 2430939A1 FR 7917796 A FR7917796 A FR 7917796A FR 7917796 A FR7917796 A FR 7917796A FR 2430939 A1 FR2430939 A1 FR 2430939A1
Authority
FR
France
Prior art keywords
phenoxy
prostatrienoiques
substitue
ceto
production process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7917796A
Other languages
English (en)
Other versions
FR2430939B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Publication of FR2430939A1 publication Critical patent/FR2430939A1/fr
Application granted granted Critical
Publication of FR2430939B1 publication Critical patent/FR2430939B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

L'invention a trait au domaine de la chimie médicale. Elle concerne de nouveaux dérivés 16-phénoxy et 16(phénoxy substitué en ortho, méta ou para) d'acide (dl)-9-céto-11 alpha , 15 alpha -dihydroxy-17, 18, 19, 20-tétranorprosta-4, 5, 13-trans-triénoïque, leurs esters alkyliques inférieurs et leurs sels non toxiques, acceptables du point de vue pharmaceutique, ainsi que des procédés de production de ces composés. Les composés de l'invention ont des activités semblables à celles des prostaglandines et sont donc intéressants à utiliser dans le traitement de mammifères dont l'état nécessite l'administration de prostaglandines. Ils sont particulièrement utiles comme inhibiteurs de la sécrétion gastrique d'acide et comme agents permettant de combattre les crises d'asthme, en raison de leur activité broncho-dilatatrice.
FR7917796A 1978-07-10 1979-07-09 Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant Granted FR2430939A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/922,957 US4178457A (en) 1978-07-10 1978-07-10 (dl)-16-Phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acid derivatives and processes for the production thereof

Publications (2)

Publication Number Publication Date
FR2430939A1 true FR2430939A1 (fr) 1980-02-08
FR2430939B1 FR2430939B1 (fr) 1981-08-14

Family

ID=25447871

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7917796A Granted FR2430939A1 (fr) 1978-07-10 1979-07-09 Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant

Country Status (26)

Country Link
US (1) US4178457A (fr)
EP (1) EP0008003B1 (fr)
JP (1) JPS5513282A (fr)
KR (1) KR890002773B1 (fr)
AT (1) ATE2427T1 (fr)
AU (1) AU527516B2 (fr)
CA (1) CA1149802A (fr)
CS (1) CS209927B2 (fr)
DD (1) DD146179A5 (fr)
DE (2) DE2964709D1 (fr)
DK (1) DK157753C (fr)
ES (1) ES482330A1 (fr)
FI (1) FI69061C (fr)
FR (1) FR2430939A1 (fr)
GB (1) GB2025413B (fr)
HK (1) HK41384A (fr)
HU (1) HU184185B (fr)
IT (1) IT1121462B (fr)
MY (1) MY8500576A (fr)
NO (4) NO150836C (fr)
NZ (1) NZ190924A (fr)
PL (4) PL121778B1 (fr)
SG (1) SG82483G (fr)
SU (1) SU1031407A3 (fr)
YU (3) YU41870B (fr)
ZA (1) ZA793293B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328245A (en) * 1981-02-13 1982-05-04 Syntex (U.S.A.) Inc. Carbonate diester solutions of PGE-type compounds
US4358603A (en) * 1981-04-16 1982-11-09 Syntex (U.S.A.) Inc. Acetal stabilized prostaglandin compositions
US4409239A (en) * 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
US4600785A (en) * 1983-12-22 1986-07-15 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4804787A (en) * 1983-12-22 1989-02-14 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4912235A (en) * 1983-12-22 1990-03-27 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
DE3414509A1 (de) * 1984-04-13 1985-10-24 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 9-halogen-prostaglandine
NZ212914A (en) * 1984-07-31 1988-08-30 Syntex Inc Tetranorprostaglandin derivatives and pharmaceutical compositions
US5057621A (en) * 1984-07-31 1991-10-15 Syntex (U.S.A.) Inc. 11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4792617A (en) * 1984-07-31 1988-12-20 Syntex (U.S.A.) Inc. 11-substituted-16-phenoxy and 16-substituted phenoxy-prostatrienioc acid derivatives
US4618696A (en) * 1984-07-31 1986-10-21 Syntex (U.S.A.) Inc. 9-oxo-15α-hydroxy-16-phenoxy and 16-substituted phenoxy 17,18,19,20-tetranorprosta-4,5,13,(E)-trienoates
US4778904A (en) * 1985-09-13 1988-10-18 Syntex (U.S.A.) Inc. Intermediates for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
EP0248999A3 (fr) * 1986-04-11 1988-03-16 Syntex (U.S.A.) Inc. Prostaglandines du type enprostil pour la régulation du métabolisme des lipides et hydrates de carbone
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
GB8625321D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
US4689419A (en) * 1986-11-14 1987-08-25 G. D. Searle & Co. Novel intermediate compounds in a process for producing 16-phenoxy- and 16-substituted phenoxy-9-keto-prostatrienoic acid derivatives
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US8966971B2 (en) * 2008-07-28 2015-03-03 Ford Global Technologies, Llc Vehicle engine with fluid measuring system
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
JP2012507552A (ja) * 2008-10-29 2012-03-29 アエリエ・ファーマシューティカルズ・インコーポレーテッド プロスタグラジンのアミノ酸塩
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985791A (en) * 1975-06-23 1976-10-12 Syntex (U.S.A.) Inc. 16-Phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985791A (en) * 1975-06-23 1976-10-12 Syntex (U.S.A.) Inc. 16-Phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives

Also Published As

Publication number Publication date
YU168579A (en) 1983-02-28
FI792149A (fi) 1980-01-11
IT1121462B (it) 1986-04-02
CA1149802A (fr) 1983-07-12
NO840257L (no) 1980-01-11
NO840258L (no) 1980-01-11
NO152212C (no) 1985-08-21
DK157753B (da) 1990-02-12
FI69061C (fi) 1985-12-10
NO792283L (no) 1980-01-11
JPS6210227B2 (fr) 1987-03-05
HU184185B (en) 1984-07-30
HK41384A (en) 1984-05-18
DE2927715A1 (de) 1980-01-24
FI69061B (fi) 1985-08-30
NO150836C (no) 1985-01-09
JPS5513282A (en) 1980-01-30
MY8500576A (en) 1985-12-31
CS209927B2 (en) 1981-12-31
GB2025413B (en) 1982-07-28
YU41870B (en) 1988-02-29
DE2964709D1 (en) 1983-03-17
PL217001A1 (fr) 1980-03-24
YU73586A (en) 1986-12-31
DD146179A5 (de) 1981-01-28
YU44553B (en) 1990-08-31
NO152296C (no) 1985-09-04
KR890002773B1 (ko) 1989-07-28
EP0008003B1 (fr) 1983-02-09
YU73686A (en) 1986-12-31
NO152212B (no) 1985-05-13
PL120604B1 (en) 1982-03-31
ES482330A1 (es) 1980-08-16
DK157753C (da) 1990-07-09
NO152296B (no) 1985-05-28
NO150836B (no) 1984-09-17
IT7968428A0 (it) 1979-07-09
PL120632B1 (en) 1982-03-31
DE2927715C2 (fr) 1987-08-27
YU44554B (en) 1990-08-31
SG82483G (en) 1984-08-03
SU1031407A3 (ru) 1983-07-23
DK288879A (da) 1980-01-11
PL120633B1 (en) 1982-03-31
ZA793293B (en) 1981-02-25
FR2430939B1 (fr) 1981-08-14
GB2025413A (en) 1980-01-23
ATE2427T1 (de) 1983-03-15
AU527516B2 (en) 1983-03-10
NZ190924A (en) 1980-11-28
US4178457A (en) 1979-12-11
NO152211B (no) 1985-05-13
AU4864179A (en) 1980-02-07
NO152211C (no) 1985-08-21
PL121778B1 (en) 1982-05-31
EP0008003A1 (fr) 1980-02-20
NO840256L (no) 1980-01-11

Similar Documents

Publication Publication Date Title
FR2430939A1 (fr) Nouveaux derives d'acides (dl)-16-(phenoxy ou phenoxy substitue)-9-ceto- prostatrienoiques, leur procede de production et medicament les contenant
FR2450832A1 (fr) Nouveaux 3-(1-imidazolylalkyl) indoles, leur procede de production et composition pharmaceutique les contenant
ATE322283T1 (de) Transdermale verwendung von sekretin zur behandlung von autismus
US5079261A (en) Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis
ATE208397T1 (de) Arylsubstituierte 5,5 verknüpfte aromatische nitroverbindungen als entzündungshemmende wirkstoffe
WO2002003996A1 (fr) Utilisation de saponines de triterpenoide de type dammarane
JPS62240619A (ja) 制癌剤
FR2404625A1 (fr) Nouveaux 4-aminocyclohexanols et composition pharmaceutique les contenant
GEP19960656B (en) Method for production of phenylalkylamines or its pharmaceutically acceptable salts
JPS62158210A (ja) Ｌ−ド−パの直腸吸収形態
EP1397105A1 (fr) Methodes d'inhibition de l'angiogenese
AU2002311985A1 (en) Methods for inhibiting angiogenesis
JPH05213745A (ja) 病態生理学的原因による刺激障害及びそれに因る病気並びにアレルギー病の治療薬及びその製法
US4910224A (en) Method of modifying the lipid structure and function of cell membranes and pharmaceutical compositions for use therein
FR2555050A1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
MX163574B (es) Procedimiento para preparar una composicion farmaceutica para inhalacion conteniendo un gangliosido
HUP0400549A2 (hu) Új imidazolszármazékok és eljárás előállításukra, és ezeket tartalmazó gyógyszerkészítmények
EP0499544A2 (fr) Utilisation de dérivés de tétrahydrothiénopyridine comme inhibiteurs de l'angiogénèse
KR20230121808A (ko) 약제학적 활성 화합물로서 칸나비노이드 유도체 및이의 제조 방법
FR2591483A1 (fr) Compositions pharmaceutiques antivirales et antitumorales.
FR2434162A1 (fr) Nouveaux derives de 4-amino-2-piperidino-quinazoline, leur procede de production et medicament les contenant
EP1656131A2 (fr) Utilisation de la betaine pour le traitement des arterites
FR2375222A1 (fr) Nouveaux composes du type (2-benzothiazolyl)oxamate, leur procede de preparation et medicament les contenant
FR2481271A1 (fr) Derives de la nonaprenylamine, leurs sels acides d'addition et leur utilisation dans des compositions pharmaceutiques
FR2423490A1 (fr) Nouveaux 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-n-(1h-tetrazol-5-yl) carboxamides eventuellement substitues, leur procede de production et medicament les contenant

Legal Events

Date Code Title Description
ST Notification of lapse